Author Archive | StuChapman

­­Revisiting the VHL Connection:
How a Common Pathway Now More Closely Links Sporadic RCC,
VHL-Associated Syndromes

Eric Jonasch, MD Professor, Department of Genitourinary Medical Oncology Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, Texas   Keywords: von Hippel Lindau (VHL) disease; syndrome; hereditary, genetic mutation; hemangioblastoma; retinal; hypoxia inducible factor; VEGF. Corresponding Author: Eric Jonasch, MD, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of […]

Continue Reading

The Classification and Treatment of
Non-Clear Cell Renal Cell Carcinoma

          Sandy T. Liu, MD1,4,5, Karlton Wong, MD,1 Gavin Hui, BA,2 Kristen Kelley, MD,3 Allan J. Pantuck, MD,4,5 Alexandra Drakaki, MD, PhD1,4,5 1Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 2David Geffen School of Medicine at University of California Los […]

Continue Reading

Late Relapsing Renal Cell Carcinoma:
A Brief Review Suggests Expected PFS and OS 5 Years and Beyond after Nephrectomy

Marc R. Matrana, MD, MS, FACP Director, Precision Cancer Therapies Program Ochsner Cancer Institute New Orleans, Louisiana   Keywords: Late relapsing renal cell carcinoma, recurrence of kidney cancer more than 5 years following nephrectomy, targeted therapy. Corresponding Author: Dr. Marc R. Matrana, Third Floor, Benson Cancer Center, 1514 Jefferson Highway, New Orleans, LA  70121, E-mail: […]

Continue Reading